Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?-Reference-Cited by-同舟云学术

Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?

Published:2018-05 Issue:2 Volume:36 Page:287-298
ISSN:0733-8651
Container-title:Cardiology Clinics
language:en
Short-container-title:Cardiology Clinics

Author:

Ellis Katrina L.,Watts Gerald F.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Cardiology and Cardiovascular Medicine,General Medicine

Reference65 articles.

1. Lipoprotein(a) as a cardiovascular risk factor: current status;Nordestgaard;Eur Heart J,2010

2. The renaissance of lipoprotein(a): brave new world for preventive cardiology?;Ellis;Prog Lipid Res,2017

3. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100;Koschinsky;J Biol Chem,1993

4. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen;McLean;Nature,1987

5. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study;Kamstrup;Circulation,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ins and outs of lipoprotein(a) assay methods;Archives of Medical Science – Atherosclerotic Diseases;2024-01-03

2. Lipid Parameters and Proprotein Convertase Subtilisin/Kexin Type 9 in Healthy Lebanese Adults;Metabolites;2022-07-26

3. Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren;Metabolites;2022-05-31

4. Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis;eBioMedicine;2022-02

5. Lipoprotein(a) as a unique primary risk factor for early atherosclerotic peripheral arterial disease;BMJ Case Reports;2021-06